Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pancreatitis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    January 2017
  1. NEOPTOLEMOS JP, Palmer DH, Ghaneh P, Psarelli EE, et al
    Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2017 Jan 24. pii: S0140-6736(16)32409.
    PubMed     Text format     Abstract available


  2. DEPLANQUE G, Demartines N
    Pancreatic cancer: are more chemotherapy and surgery needed?
    Lancet. 2017 Jan 24. pii: S0140-6736(17)30126.
    PubMed     Text format    


    June 2016
  3. KO AH
    Raising the bar for the adjuvant treatment of pancreatic cancer.
    Lancet. 2016 Jun 2. pii: S0140-6736(16)30680.
    PubMed     Text format    


  4. UESAKA K, Boku N, Fukutomi A, Okamura Y, et al
    Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
    Lancet. 2016 Jun 2. pii: S0140-6736(16)30583.
    PubMed     Text format     Abstract available


    May 2016
  5. MILOSEVIC I, Drysdale H, Goldacre B
    Nanoliposomal irinotecan in metastatic pancreatic cancer.
    Lancet. 2016;387:1997.
    PubMed     Text format    


  6. CHEN LT, Wang-Gillam A, Von Hoff DD, Bayever E, et al
    Nanoliposomal irinotecan in metastatic pancreatic cancer - Authors' reply.
    Lancet. 2016;387:1997.
    PubMed     Text format    


    April 2016
  7. LUO H, Zhao L, Leung J, Zhang R, et al
    Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial.
    Lancet. 2016 Apr 28. pii: S0140-6736(16)30310.
    PubMed     Text format     Abstract available


  8. DE MESTRAL C
    Simple pharmacological prophylaxis for post-ERCP pancreatitis.
    Lancet. 2016 Apr 28. pii: S0140-6736(16)30312.
    PubMed     Text format    


    February 2016
  9. MAJUMDER S, Chari ST
    Chronic pancreatitis.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00097.
    PubMed     Text format     Abstract available


    January 2016
  10. KAMISAWA T, Wood LD, Itoi T, Takaori K, et al
    Pancreatic cancer.
    Lancet. 2016 Jan 29. pii: S0140-6736(16)00141.
    PubMed     Text format     Abstract available


    November 2015
  11. OETTLE H, Lehmann T
    Gemcitabine-resistant pancreatic cancer: a second-line option.
    Lancet. 2015 Nov 23. pii: S0140-6736(15)01035.
    PubMed     Text format    


  12. WANG-GILLAM A, Li CP, Bodoky G, Dean A, et al
    Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
    Lancet. 2015 Nov 20. pii: S0140-6736(15)00986.
    PubMed     Text format     Abstract available


    September 2015
  13. DA COSTA DW, Bouwense SA, Schepers NJ, Besselink MG, et al
    Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial.
    Lancet. 2015;386:1261-8.
    PubMed     Text format     Abstract available


  14. DE MESTRAL C, Nathens AB
    Cholecystectomy in mild gallstone pancreatitis: don't defer.
    Lancet. 2015;386:1218-9.
    PubMed     Text format    


    February 2015
  15. KHALED YS, Wright K, Melcher A, Jayne D, et al
    Anti-cancer effects of oncolytic viral therapy combined with photodynamic therapy in human pancreatic cancer cell lines.
    Lancet. 2015;385 Suppl 1:S56.
    PubMed     Text format     Abstract available


  16. FRAMPTON AE, Castellano L, Colombo T, Giovannetti E, et al
    Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression.
    Lancet. 2015;385 Suppl 1:S37.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: